HOME >> MEDICINE >> NEWS
Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting

To learn about the exciting new directions in drug therapy for osteoporosis and other bone diseases, media are invited to attend Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis, a two-day meeting focusing on the current and future status of bone-building anabolic skeletal agents for osteoporosis treatment. This ground-breaking meeting is cosponsored by the American Society for Bone and Mineral Research and the National Institutes of Health.

The first of the therapeutic skeletal anabolic agents, parathyroid hormone (PTH), has now been on the market for more than a year. The success of this drug, coupled with recent advances in the understanding of bone formation and identification of new potential signaling molecules and targets for anabolic skeletal agents, has revolutionized the field of osteoporosis therapy. This means that clinicians and researchers can now approach osteoporosis therapeutically in two completely different ways: by slowing bone loss (the old way) and by stimulating new bone formation (the new, anabolic way).

Speakers at the May 24-25 meeting include world-renowned scientists Thomas Clemens, Ph.D., Susan Greenspan, M.D., Thomas Einhorn, M.D., Mark Johnson, Ph.D., Sundeep Khosla, M.D., and Stavros Manolagas, M.D., Ph.D.

This scientific meeting is also co-sponsored by The American Academy of Orthopaedic Surgeons, The Endocrine Society, The International Society for Clinical Densitometry, The National Institute of Diabetes and Digestive and Kidney Diseases, The National Institute on Aging, The National Institute of Arthritis and Musculoskeletal and Skin Diseases, The National Institute of Child Health and Human Development, The National Institute of Dental and Craniofacial Research, The National Osteoporosis Foundation and The Osteogenesis Imperfecta Foundation.


'"/>

Contact: Kara Dress
kdress@smithbucklin.com
202-367-2434
The Endocrine Society & The Hormone Foundation
18-May-2004


Page: 1

Related medicine news :

1. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
2. Advances in plasma physics at Annual APS Meeting
3. Advances in plasma physics at Annual APS Meeting
4. Advances in understanding brain circuits responsible for tics in Tourettes shed light on disorder
5. Advances emerging in hepatitis management
6. Advances in prevention and treatment research hold promise for pipeline
7. Advances in MRI imaging may lead to new standards for faster diagnosis of multiple sclerosis
8. Peanut Allergy: Major Advances in Treatment and Education
9. "Radical" Discovery Advances Medicine and Plastics
10. Advances in On the Spot tests have huge public health implications
11. Immunex Advances CD40 Ligand To Phase II Clinical Trial In People With Metastatic Kidney Cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2019)... ... November 20, 2019 , ... Bihler 4Slide-NC® Safety Enclosures ... of which are potentially dangerous, due to the possibility of clothing being grabbed, ... which of these occurrences can lead to severe injuries. , The Bihler 4Slide-NC® ...
(Date:11/19/2019)... ... November 19, 2019 , ... From nourishing skin and ... consumers make and maintain healthy changes, just in time for the holidays. The ... and CBD Peppermint Oil Blend as well as updated its AMPED™ Hydrate drink. ...
(Date:11/19/2019)... SANGERFIELD, N.Y. (PRWEB) , ... November 19, 2019 , ... ... his first marathon with a bike ride along the Charles River in Boston. Days ... seemed familiar to him, yet he struggled to know exactly who all of them ...
(Date:11/19/2019)... ... ... “In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy ... on Amazon in the USA, Canada, and United Kingdom in 10 categories including Cell ... was named a hot new release in multiple categories including Cell Biology, Respiratory, and ...
(Date:11/19/2019)... ... November 19, 2019 , ... Bright Day Big Blocks, ... is announcing the launch of their Gift Of Play initiative. Organizations are encouraged ... theirs. , Co-Founders of Bright Day Big Blocks, Laurel Tucker and David Krishock decided ...
Breaking Medicine News(10 mins):
(Date:11/21/2019)... ... November 21, 2019 , ... ... management of ocular surface disease, today announced that FocalPoint Holdings, a privately-held ... selected as the preferred partner. FocalPoint Holdings and its subsidiaries will now ...
(Date:11/20/2019)... VANCOUVER, British Columbia (PRWEB) , ... November 20, ... ... Novel Proprietary Test Formulation on Organs Specific Biomarkers” by Inthirani Arul has been ... Kingdom in 3 categories including Brain, Cardiovascular, and Medical Atlases. , The ...
(Date:11/19/2019)... ... November 19, 2019 , ... There are ... to get and stay healthy and pain-free. Chiropractic is a healthcare field that ... also address the effects of these conditions on the body’s general health. , ...
Breaking Medicine Technology:
Cached News: